47 results about "Octadecatrienoic acid" patented technology

Here the inventors provide a composition for topical application to the skin of animal comprising stearidonic acid in combination with one or octadecatrienoic acids (CODTAs). Preferably the composition comprises echium oil as a source of the stearidonic acid, and a plant lipid as a source of octadecatrienoic acid, such as borage oil (Borago officinalis), wheat germ oil (Triticum vulgare) rosehip oil (refined; Rosa mosqueta), jacaranda oil (Jacandra mimosi folia), and / or calendula oil (Calendula officinalis). The composition of the invention increases collagen I secretion and thus has particular utility for promoting collagen production in skin.

The present invention relates to a combination of a hermetically sealed, substantially air-tight container and a nutritional composition. The container of the present invention is adapted for the convenient transport, and storage of a single daily oral dose of a nutritional composition containing a fatty acid, for example, diacyl glycerol, an octadecatrienoic acid, an octadecadienoic acid, linolenic acid, linoleic acid, conjugated linoleic acid (CLA) or a combination thereof. In a preferred embodiment, the present invention relates to the use of the c9, t11 and t10, c12 isomers of CLA in a nutritional composition. The wide range of health benefits associated with consumption of these CLA fatty acids is well known. Furthermore, the invention relates to a container that substantially prevents CLA lipid oxidation caused by exposure to air.

The invention discloses acquisition and application of grease-producing monoraphidium LB50, and relates to screening and culture utilization technologies of the grease-producing monoraphidium. An algae species obtained by separating from field environment is subjected to 18S rDNA sequence analysis and morphological identification and is determined as a member of monoraphidium, and the sequence is shown as SEQ NO.1. The grease-producing monoraphidium LB50 is capable of bearing high-concentration sodium bicarbonate, is easy for open-type culture and is rich in grease; and when the growth and collection speed is kept at 22.2 g / m<2>*d, the grease content reaches 30.4% by dry weight of a cell, and aliphatic acid contained in grease contains octadecatrienoic acid and octadecatetraenoic acid which account 15% or more of aliphatic acid.

The present invention relates to an edible oil and its processing method, in particular, it relates to a green tea oil made up by using green tea seeds as raw material and its preparation method. The composition of said green tea oil includes (by wt%) 52-68% of oleic acid, 16-28% of linoleic acid, 0.8-3% of octadecatrienoic acid, 10-18% of palmic acid, 2.3-2.9% of tea-polyphenol, 1-4% of stearic acid, tea saponin 4.8-5.5ppm, flavone 5.6-6.0mg / kg, caffeine 0.2066-0.2166(%, m / v) and vitamin E 250-350mg / kg. The preparation method of said green tea oil includes the following steps: raw material treatment, oil pressing, filtering, filling and storage.

An application of refined fur seal oil "OMEGA 3" in preparing the medicines for preventing and treating senile dementia and apoplexy sequela is disclosed. Said defined fur seal oil "OMEGA 3" contains octadecadienoic acid, octadecatrienoic acid, EPA, DPA, DHA, squalene, VE, unsaturated fatty acid, and saturated fatty acid.

A medicine for treating various diseases such as women's climacteric syndrome, osteoporosis, mental depression, premature ovarian failure, premenstrual tension syndrome, hyperthyroidism, male and female infertility, hair loss and white hair, and is characterized in that it It is composed of fatty acids in the following weight percent range: hexadecanoic acid 8-32%, hexadecenoic acid 11-35%, octadecenoic acid 13-33%, octadecanoic acid 0.3-2.5%, octadecanoic acid Carbadienoic acid 11-33%, octadecatrienoic acid 3-15%. Compared with other drugs, the drug composition is simple, belongs to the target organ agonist, and has an independent reversible regulation function on the second messenger of the body. It is a medicine with high curative effect, safety and simplification.

A method for the preparation and purification of conjugated linolenic acids is described. The method comprises blending a mixture of vegetable oils and or fats including various concentrations of alpha or gamma and or both linolenic acids with a base. The method transforms approximately over two thirds of α-linolenic acid (9Z,12Z,15Z-octadecatrienoic acid) into 9Z,11E,15Z-octadecatrienoic acid and 9Z,13E,15Z-octadecatrienoic acid. The method also transforms gamma-linolenic acid (6Z,9Z,12Z-octadecatrienoic acid) into 6Z,8E,15Z-octadeccatrienoic acid and 6Z,10E,12Z-octadecatrienoic acid. In all cases, geometrical isomers and fully conjugated isomers are also produced.

The invention relates to a health product, which is characterized in that: the health product comprises timnodonic acid, docosahexaenoic acid, hexadecenoic acid, octadecenoic acid, octadecadienoic acid, octadecatrienoic acid, eicosatetraenoic acid and docosapentaenoic acid, wherein the mass summation of the timnodonic acid and the docosahexaenoic acid accounts for 35 to 40 percent of the total mass, and the mass summation of the hexadecenoic acid, the octadecenoic acid, the octadecadienoic acid, the octadecatrienoic acid, the eicosatetraenoic acid and the docosapentaenoic acid accounts for 60 to 75 percent of the total mass. The contents of fish oil extracts EPA and DHA prepared by the method are between 35 and 40 percent; and the deep sea fish oil prepared from the extracts taken as main raw materials has the advantages of having an obvious lipid-reducing effect, diversifying active ingredients, and achieving the effects of inhibiting platelet aggregation, lowering neutral lipid in blood, lowering cholesterol of low density lipoprotein and low density lipoprotein, increasing high density cholesterol, lowering blood viscosity, lowering cholesterol, preventing heart cerebrovascular diseases, reducing arterial pressure, alleviating gout and rheumatoid arthritis, improving the development of the brain and eyes and the like, so that the health product is the best choice of middle and old-aged people.

According to a technical scheme on the first aspect, the invention provides a drug for treatment of polycystic ovary syndrome (PCOS) and abnormal glucose metabolism coexisting diseases. The drug is characterized by including the following four fatty acid components by mass: 17-22% of palmitic acid, 11-23% of hexadecenoic acid, 22-28% of 9-octadecenoic acid, 13-35% of 9, 12, 15-octatecatrienoic acid, and the balance pharmaceutically acceptable additives or excipients. The components are mixed according to compatibility to be prepared into soft capsules and other oral preparations, so that the insulin receptor substrate (IRS) protein level can be effectively reduced so as to inhibit the glucose way, the insulin receptor active time can be increased and the insulin level can be enhanced, and the insulin sensitivity is increased so as to facilitate the reduction of insulin resistance degree. Thus, the drug can have the functions of improving and recuperating ovary ovulatory dysfunction, i.e. PCOS and abnormal glucose metabolism diseases. Compared with other drugs, the drug has simple components, and belongs to highly effective, safety, and simplified drugs.

The invention belongs to the technical field of medicine production research development, and relates to isolation and identification as well as application of volatile oil elements of Parasenecio firmus leaf. The isolation and identification of the volatile oil elements of the Parasenecio firmus leaf are realized by the following steps of: weighing dried Parasenecio firmus leaf, and extracting ultrasonically by a water steam distillation method to obtain the volatile oil; and analyzing the obtain volatile oil by utilizing a 6890 / 5973N gas chromatograph-mass spectrometer. The obtain volatile oil mainly comprises the following chemical elements in proportion: 18.98% of n-palmitic acid, 9.89% of 1-tridecylene, 8.05% of caryophyllene epoxide, 6.04% of (S)-undeca-cycloolefin, 3.84% of 9,12,15-octadecatrienoic acid, 2.97% of (-)-spathulenol, 2.83% of kaurene and 2.12% of caryophyllene. The volatile oil is used for preparing pharmaceutical preparation capable of restraining escherichia coli, streptococcus, Salmonella, Pasteurella and staphylococcus aureus.

A health-care mixed plant oil containing linolenic acid for decreasing blood fat and blood viscosity contains gamma-linolenic acid (0.4-1.8 wt.%), alpha-linolenic acid (40-85 wt.%) and beta-linolenic acid (0.28-1.5 wt.%). It can be directly eaten or made into capsule or tables. Its advantages are quickly taking its effect and low cost.

An inductive production-increase agent for the honeybee pollination on flowering plants comprises (E)-9-Oxodec-2-enoic acid (9-ODA), R (-)-9-hydroxy-(E)-2-decenoic acid (R(-)-9HDA), S(+)-9-hydroxy-(E)-2-decenoic acid (S (+) -9HDA), Methyl 4-hydroxybenzoate (HOB), 4-hydroxy-3-methoxyphenylacetic (HVA), 9-Octadecenoic acid methyl ester (methyl oleate), (E)-4-(4-Hydroxy-3-methoxypheny)-3-2-propen-1-ol (coniferyl alcohol), hexadecanol and (Z9, Z12, Z15)-9, 12, 15-octadecatrienoic acid (linolenic acid); the invention can effectively induce a honeybee to pollinate on flowering plants. The inductive production-increase agent has a positive effect on the production increase of honeybee pollination on blueberries and cherries; it effectively extrudes the application of the queen bee flowing element in the inductive production increase in the pollination on blueberries and cherries.

This invention relates to a new conjugated linoleic acids, a process for preparation thereof and method of use. Thus this invention is concerned with the preparation and purification of conjugated linoleic acids from materials rich in alpha or gamma linoleic acids. The reaction produces a mixture containing a 1:1 ratio of 9Z, 11E, 15Z-octadecatrienoic acid and 9Z, 13E, 15Z-octadecatrieonic acid. The mixture can be purified up to 90% by liquid chromatography, crystallization or urea crystallization. The mixture of 1:1 9Z, 11E, 15Z-octadecatrienoic acid and 9Z, 13E, 15E, 15Z-octadecatrienoic acid have anticancerous activities.

A method for culturing loaches in a pond comprises steps as follows: pond selection and treatment, addition of young loaches, pond management, feed addition and disease prevention. By means of the culturing method, survival of contaminating microorganisms in the pond can be effectively inhibited, subacidity of water is well guaranteed, an excellent environment is provided for growth of the loaches, parasitic diseases and trichodiniasis on the loaches can be reduced, the survival rate of the loaches is increased, the loaches cultured with the culturing method grow fatter, and the content of docosahexaenoic acid and octadecatrienoic acid in fat is higher.

The invention discloses a potato peptide nutrient. The potato peptide nutrient comprises the following ingredients in percentage by weight: 1-85% of potato peptide and linoleic acid, octadecatrienoic acid, oleic acid, saponin, flavonoids, phospholipid, bifidus factor, vitamins, carotene, microelements such as calcium, magnesium, potassium, zinc and the like, as well as vitamins and glucose which account for the remaining percentage. The potato peptide nutrient is prepared by the following steps: soaking sliced potatoes by dilute hydrochloric acid or acetic acid; removing acid by water; making the sliced potatoes into pulp and grinding the pulp so as to obtain a potato pulp-material; separating a soybean pulp to extract the protein; grinding the protein; adding ROHAPECTB1L enzyme and ROHAMENTCL enzyme into the grinded protein; blending the mixture and statically standing; mixing the potato pulp with the soybean pulp; treating the mixture under 6-7 atmospheric pressures at 136-150 DEG C; performing subdivision treatment and homogenization on the mixture and then adding COROLASE7089 enzyme and COROLASELPA enzyme to perform biochemical treatment; concentrating the obtained potato peptide stock solution; and then, processing the potato peptide stock solution, so that the potato peptide nutrient is prepared.

The eel oil extract contains eicosapentaenoic acid and docosahexaenoic acid in 34-50 %, and hexadecylenic acid, oleic acid, linoleic acid, elacomargaric cid, eicosatetraenoic acid and docosapentaenoic acid in 45-55 %. The present invention also discloses the preparation process of the eel oil extract and blood fat reducing health product with the extract. The eel oil extract of the present invention has the functions of inhibiting platelet aggregation, lowering cholesterol, preventing cardiac and cerebral vascular diseases, etc.

The invention provides an analytical kit for detecting four free fatty acids (alpha-octadecatrienoic acid, eicosapentaenoic acid, omega3-docosapentaenoic acid and docosahexaenoic acid) in human bloodspots through high performance liquid chromatography-tandem mass spectrometry. The analytical kit specifically comprises replacement matrix pretreatment, dried blood spot sample treatment and the like. The method has the advantages of high sensitivity, short time and improved detection efficiency.

Provided is a medicine controlling and curing chronic aplastic anemia. The medicine is composed of a mixture comprising, by weight percentage, 12 to 32 percent of hexadecanoic acid , 9.0 to 34 percent of hexadecylenic acid, 15.3 to 32 percent of 9-octadecenoic acid, 0.3 to 4.6 percent of stearic acid, 10.8 to 26 percent of 9, 12-octadecadienoic acid and 3.6 to 36 percent of 9,12,15- octadecatrienoic acid. Compared to other medicines, the medicine has simple components and possesses effects of activating marrow hematopoiesis, promoting marrow cell fifferentiation and being a target organ stimulant. The medicine can achieve the effect of adjusting and improving hematopoiesis microenvironment and helping a body perform multi-way signal transduction. The medicine is characterized by good curative effect, safety and simplicity.

The invention relates to a diagnostic marker for neuropsychiatric lupus and a detection kit thereof. Specifically, the invention relates to application of 21 metabolites (L-asparagine, epinephrine, guanidinoacetic acid, neopterin, gluconolactone, triethylamine, alpha-D-glucose, sarcosine, ethyl laurate, 2-acetylfuran, 1,3-Diisopropylbenzene, n-caprylaldehyde, naphthalene, trans-2-octene-1-ol, beta-aminopropionic acid, spermidine, inositol, methyl octadecatrienoate, Pulegone, methyl dihydrojasmonate, 1-pentadecanol as biomarkers alone or in combination, and more particularly, to a method for neuropsychiatric lupus diagnosis. The invention relates to a method for detecting biomarkers in body fluid (such as cerebrospinal fluid) of an NPSLE patient by utilizing biomarker detection technology platforms such as a mass spectrometry technology, enzyme-linked immunosorbent assay (ELISA) and a protein chip.

Here the inventors provide a composition for topical application to the skin of animal comprising stearidonic acid in combination with one or more octadecatrienoic acids (CODTAs). Preferably the composition comprises echium oil as a source of the stearidonic acid, and a plant lipid as a source of octadcatrienoic acid, such as borage (Borago officinalis), wheat germ oil (Triticum vulgare), rosehip oil (refined; Rosa mosqueta), jacaranda oil (Jacandra mimosa folia), and / or calendula oil (Calendula officinalis). The composition of the invention increases collagen I secretion and thus has particular utility for promoting collagen production in skin.

The invention relates to the technical field of anti-corrosion and anti-static coating, and discloses an anti-static epoxy ester modified styrene-acrylic resin anti-corrosion coating, which comprisesthe following raw materials in parts by weight: epoxy ester modified styrene-acrylic resin, modified styrene-acrylic resin curing agent, catalyst, distilled water, filler, cosolvent and 0.1-0.3 partsof organic silicone defoamer, wherein the modified styrene-acrylic resin curing agent is hydrophilic polyamide curing agent and the catalyst is benzoyl peroxide. According to the antistatic epoxy ester modified styrene-acrylic resin anticorrosive coating, the epoxy ester modified styrene-acrylic resin is formed by using epoxy resin and gamma-linoleic acid as raw material to synthesize styrene-acrylic emulsion and in the process of emulsion film formation, it can be further crosslinked and cured, which can solve the problem of insufficient compactness of the coating film and improve the anti-corrosion performance. The catalyst is benzoyl peroxide, and a small amount of polyacyl ester benzene methyl acrylate polymer is generated to form a network conductive network, so that the emulsion hasstable conductive performance, thus the coating has anti-static function.

The invention relates to a method for applying the polyene acid calcium in the field of the medical treatment and cosmetology. At present, the polyene acid calcium is never applied in the field of the medical treatment and cosmetology. The invention consists of the polyene acid calcium, the glycerin, the octadecyl alcohol, the monoglyceride, the white mineral oil, the albolene, the P20 emulgator, the propylene glycol, the preservative K400 and the essence and water. The polyene acid calcium is calendic acid calcium, linolic acid calcium or octadecenoic acid calcium. The invention has the efficacies of resisting crease, whelks, acnes, stains and dead skins, reducing sweat pores, removing scars caused by the whelks, sunburn, graze, skin injury, die burn and frostbite and preventing freezing, framing, aging, and sunburn, repairing and regenerating skins and repairing the damaged skins due to diversified reasons. The invention has the advantages of remarkable medical efficacy, low production cost, no toxic and side effects, safety and reliability and easy popularization.

The invention discloses an unsaturated fatty acid capsule. The capsule contains, by weight, 20-30 parts of octadecatrienoic acid, 10-15 parts of docosahexenoic acid, 13-16 parts of eicosapentaenoic acid and 50-80 parts of soybean protein. The unsaturated fatty acid capsule is prepared through the compatibility of octadecatrienoic acid, docosahexenoic acid and eicosapentaenoic acid, so the consumption of deep sea fish oil is reduced, and the production cost of fatty acid capsules is reduced.

The invention relates to blend oil containing 48% of linoleic acid and 12% of linolenic acid in a ratio of 4:1, which mainly takes selected perilla oil, bean oil and olive oil as raw materials and has the main advantages of solving the problems of low content of omega-3 (linolenic acid) and proportional imbalance of linoleic acid and linolenic acid and remedying the shortage that the omega-3 (linolenic acid) is generally lacked in a human body, wherein the omega-3 (linolenic acid) is octatecatrienoic acid which can be used for preventing the platelet aggregation and reducing the generation of thrombotic diseases; the generated EPA (EicosaPentaenoic Acid) which is called dustman of blood vessel by medical experts has the effects of lowering the blood lipid, lowering the blood viscosity, improving the blood circulation and softening the blood vessel; and the generated DHA (DocosaHexaenoic Acid) which is called plant brain gold by nutritionists has the effects of replenishing the brain nutrition, preventing the senile dementia and improving the vision. By means of the blend oil, the epidemics of three high and four diseases and the generation of various chronic diseases such as cancers and the like are controlled from the source of foodstuffs.

The invention relates to the iatrochemistry field, in particular to a method for treating burn and scald, sunburn, bedsore, ulceration, frostbite and wound. Octadecadienoic calcium is not applied in the disease therapy field at present. In the invention the octadecadienoic calcium is made into ointment or oil-type spraying agent for external use; the octadecadienoic calcium is got by eleostearic acid reacting with sodium bicarbonate and then in liquid-liquid reaction with calcium hydroxide water, or by eleostearic acid glyceride reacting with calcium hydroxide. The invention brings evident effect to burn and scald, sunburn, bedsore, ulceration, frostbite and wound, cut fail to heal and the postoperative long-term ulceration caused by anal fissure, anal fistula or genital inflammations, also to dermatophytosis, mosquito bites and inflamed acne. Low production cost, no side effects, security and reliability make the invention easy to be promoted.